世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diabetes Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5701 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、GLP-1、インスリン）、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・糖尿病治療薬の市場動向 ・企業の競争状況、市場シェア ・糖尿病治療薬の種類別市場規模と予測2016-2027（錠剤、GLP-1、インスリン） ・糖尿病治療薬の用途別市場規模と予測2016-2027（1型糖尿病、2型糖尿病） ・糖尿病治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Merck & Co.、Novo Nordisk、Eli Lilly、Boehringer Ingelheim、Novartis、Johnson & Johnson、AstraZeneca、Takeda、Bayer、Tonghua DongBao、Hua Dong、Ganlee、Biocon） ・結論

Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

Market Analysis and Insights: Global Diabetes Treatment Drugs Market
The global Diabetes Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Treatment Drugs market.

Global Diabetes Treatment Drugs Scope and Market Size
Diabetes Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
GLP-1
Insulin

Segment by Application
Type 1 Diabetes
Type 2 Diabetes

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Merck & Co.
Novo Nordisk
Eli Lilly
Boehringer Ingelheim
Novartis
Johnson & Johnson
AstraZeneca
Takeda
Bayer
Tonghua DongBao
Hua Dong
Ganlee
Biocon

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 GLP-1
1.2.4 Insulin
1.3 Market by Application
1.3.1 Global Diabetes Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetes Treatment Drugs Market Perspective (2016-2027)
2.2 Diabetes Treatment Drugs Growth Trends by Regions
2.2.1 Diabetes Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Treatment Drugs Industry Dynamic
2.3.1 Diabetes Treatment Drugs Market Trends
2.3.2 Diabetes Treatment Drugs Market Drivers
2.3.3 Diabetes Treatment Drugs Market Challenges
2.3.4 Diabetes Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetes Treatment Drugs Players by Revenue
3.1.1 Global Top Diabetes Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Diabetes Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Treatment Drugs Revenue
3.4 Global Diabetes Treatment Drugs Market Concentration Ratio
3.4.1 Global Diabetes Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Treatment Drugs Revenue in 2020
3.5 Diabetes Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Diabetes Treatment Drugs Product Solution and Service
3.7 Date of Enter into Diabetes Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Treatment Drugs Breakdown Data by Type
4.1 Global Diabetes Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Diabetes Treatment Drugs Breakdown Data by Application
5.1 Global Diabetes Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetes Treatment Drugs Market Size (2016-2027)
6.2 North America Diabetes Treatment Drugs Market Size by Type
6.2.1 North America Diabetes Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Diabetes Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Diabetes Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Diabetes Treatment Drugs Market Size by Application
6.3.1 North America Diabetes Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Diabetes Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Diabetes Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Diabetes Treatment Drugs Market Size by Country
6.4.1 North America Diabetes Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Diabetes Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diabetes Treatment Drugs Market Size (2016-2027)
7.2 Europe Diabetes Treatment Drugs Market Size by Type
7.2.1 Europe Diabetes Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Diabetes Treatment Drugs Market Size by Application
7.3.1 Europe Diabetes Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Diabetes Treatment Drugs Market Size by Country
7.4.1 Europe Diabetes Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetes Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetes Treatment Drugs Market Size (2016-2027)
9.2 Latin America Diabetes Treatment Drugs Market Size by Type
9.2.1 Latin America Diabetes Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Diabetes Treatment Drugs Market Size by Application
9.3.1 Latin America Diabetes Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Diabetes Treatment Drugs Market Size by Country
9.4.1 Latin America Diabetes Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetes Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Diabetes Treatment Drugs Introduction
11.1.4 Sanofi Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Diabetes Treatment Drugs Introduction
11.2.4 Merck & Co. Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.2.5 Merck & Co. Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Diabetes Treatment Drugs Introduction
11.3.4 Novo Nordisk Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Diabetes Treatment Drugs Introduction
11.4.4 Eli Lilly Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Diabetes Treatment Drugs Introduction
11.5.4 Boehringer Ingelheim Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Diabetes Treatment Drugs Introduction
11.6.4 Novartis Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Diabetes Treatment Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Diabetes Treatment Drugs Introduction
11.8.4 AstraZeneca Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Diabetes Treatment Drugs Introduction
11.9.4 Takeda Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Diabetes Treatment Drugs Introduction
11.10.4 Bayer Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Tonghua DongBao
11.11.1 Tonghua DongBao Company Details
11.11.2 Tonghua DongBao Business Overview
11.11.3 Tonghua DongBao Diabetes Treatment Drugs Introduction
11.11.4 Tonghua DongBao Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.11.5 Tonghua DongBao Recent Development
11.12 Hua Dong
11.12.1 Hua Dong Company Details
11.12.2 Hua Dong Business Overview
11.12.3 Hua Dong Diabetes Treatment Drugs Introduction
11.12.4 Hua Dong Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.12.5 Hua Dong Recent Development
11.13 Ganlee
11.13.1 Ganlee Company Details
11.13.2 Ganlee Business Overview
11.13.3 Ganlee Diabetes Treatment Drugs Introduction
11.13.4 Ganlee Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.13.5 Ganlee Recent Development
11.14 Biocon
11.14.1 Biocon Company Details
11.14.2 Biocon Business Overview
11.14.3 Biocon Diabetes Treatment Drugs Introduction
11.14.4 Biocon Revenue in Diabetes Treatment Drugs Business (2016-2021)
11.14.5 Biocon Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetes Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of GLP-1
Table 4. Key Players of Insulin
Table 5. Global Diabetes Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetes Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetes Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Diabetes Treatment Drugs Market Share by Regions (2016-2021)
Table 9. Global Diabetes Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Diabetes Treatment Drugs Market Share by Regions (2022-2027)
Table 11. Diabetes Treatment Drugs Market Trends
Table 12. Diabetes Treatment Drugs Market Drivers
Table 13. Diabetes Treatment Drugs Market Challenges
Table 14. Diabetes Treatment Drugs Market Restraints
Table 15. Global Diabetes Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Diabetes Treatment Drugs Market Share by Players (2016-2021)
Table 17. Global Top Diabetes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment Drugs as of 2020)
Table 18. Ranking of Global Top Diabetes Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Diabetes Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetes Treatment Drugs Product Solution and Service
Table 22. Date of Enter into Diabetes Treatment Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Diabetes Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Diabetes Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Diabetes Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Diabetes Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Diabetes Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Diabetes Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Diabetes Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Diabetes Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Diabetes Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetes Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Diabetes Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Diabetes Treatment Drugs Product
Table 65. Sanofi Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Merck & Co. Company Details
Table 68. Merck & Co. Business Overview
Table 69. Merck & Co. Diabetes Treatment Drugs Product
Table 70. Merck & Co. Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 71. Merck & Co. Recent Development
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Diabetes Treatment Drugs Product
Table 75. Novo Nordisk Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 76. Novo Nordisk Recent Development
Table 77. Eli Lilly Company Details
Table 78. Eli Lilly Business Overview
Table 79. Eli Lilly Diabetes Treatment Drugs Product
Table 80. Eli Lilly Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 81. Eli Lilly Recent Development
Table 82. Boehringer Ingelheim Company Details
Table 83. Boehringer Ingelheim Business Overview
Table 84. Boehringer Ingelheim Diabetes Treatment Drugs Product
Table 85. Boehringer Ingelheim Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 86. Boehringer Ingelheim Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Diabetes Treatment Drugs Product
Table 90. Novartis Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Diabetes Treatment Drugs Product
Table 95. Johnson & Johnson Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Takeda Company Details
Table 102. Takeda Business Overview
Table 103. Takeda Diabetes Treatment Drugs Product
Table 104. Takeda Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 105. Takeda Recent Development
Table 106. Bayer Company Details
Table 107. Bayer Business Overview
Table 108. Bayer Diabetes Treatment Drugs Product
Table 109. Bayer Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 110. Bayer Recent Development
Table 111. Tonghua DongBao Company Details
Table 112. Tonghua DongBao Business Overview
Table 113. Tonghua DongBao Diabetes Treatment Drugs Product
Table 114. Tonghua DongBao Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 115. Tonghua DongBao Recent Development
Table 116. Hua Dong Company Details
Table 117. Hua Dong Business Overview
Table 118. Hua Dong Diabetes Treatment Drugs Product
Table 119. Hua Dong Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 120. Hua Dong Recent Development
Table 121. Ganlee Company Details
Table 122. Ganlee Business Overview
Table 123. Ganlee Diabetes Treatment Drugs Product
Table 124. Ganlee Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 125. Ganlee Recent Development
Table 126. Biocon Company Details
Table 127. Biocon Business Overview
Table 128. Biocon Diabetes Treatment Drugs Product
Table 129. Biocon Revenue in Diabetes Treatment Drugs Business (2016-2021) & (US$ Million)
Table 130. Biocon Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. GLP-1 Features
Figure 4. Insulin Features
Figure 5. Global Diabetes Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 6. Type 1 Diabetes Case Studies
Figure 7. Type 2 Diabetes Case Studies
Figure 8. Diabetes Treatment Drugs Report Years Considered
Figure 9. Global Diabetes Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Diabetes Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diabetes Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Diabetes Treatment Drugs Market Share by Regions (2022-2027)
Figure 13. Global Diabetes Treatment Drugs Market Share by Players in 2020
Figure 14. Global Top Diabetes Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Treatment Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Diabetes Treatment Drugs Revenue in 2020
Figure 16. Global Diabetes Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Diabetes Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Diabetes Treatment Drugs Market Share by Type (2016-2027)
Figure 20. North America Diabetes Treatment Drugs Market Share by Application (2016-2027)
Figure 21. North America Diabetes Treatment Drugs Market Share by Country (2016-2027)
Figure 22. United States Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetes Treatment Drugs Market Share by Type (2016-2027)
Figure 26. Europe Diabetes Treatment Drugs Market Share by Application (2016-2027)
Figure 27. Europe Diabetes Treatment Drugs Market Share by Country (2016-2027)
Figure 28. Germany Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetes Treatment Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Diabetes Treatment Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Diabetes Treatment Drugs Market Share by Region (2016-2027)
Figure 38. China Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetes Treatment Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Diabetes Treatment Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Diabetes Treatment Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetes Treatment Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Diabetes Treatment Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Diabetes Treatment Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Diabetes Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 58. Merck & Co. Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 59. Novo Nordisk Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 65. Takeda Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 67. Tonghua DongBao Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 68. Hua Dong Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 69. Ganlee Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 70. Biocon Revenue Growth Rate in Diabetes Treatment Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---